Currrent Issue: Volume 3, Number 4, 2015


Article

Solitary Plasmacytoma in the Oral cavity: A Case Report

1Department of Hematology and Medical Oncology, Kermanshah University of Medical Sciences, Kermanshah, Iran

2Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran

3Medical Biology Research Center, Kermanshah University of Medical Sciences, Kermanshah, Iran


American Journal of Cancer Prevention. 2015, 3(4), 72-73
doi: 10.12691/ajcp-3-4-1
Copyright © 2015 Science and Education Publishing

Cite this paper:
Mehrdad Payandeh, Masoud Sadeghi, Edris Sadeghi, Jalil Hamidi. Solitary Plasmacytoma in the Oral cavity: A Case Report. American Journal of Cancer Prevention. 2015; 3(4):72-73. doi: 10.12691/ajcp-3-4-1.

Correspondence to: Masoud  Sadeghi, Students Research Committee, Kermanshah University of Medical Sciences, Kermanshah, Iran. Email: sadeghi_mbrc@yahoo.com

Abstract

Background: The plasma cell neoplasms may present in soft tissue as extramedullary plasmacytomas, in bone as a solitary plasmacytoma of bone, or as part of the multifocal disseminated disease multiple myeloma. The aim of study is to report solitary plasmacytoma in the oral cavity in a male patient. Case Report: A 65-year-old male was presented to our Clinic with hypertension, high fever and loss of balance. He had nine months ago one localized lytic lesion in his thoracic vertebrae T5. The clinical reports showed multiple myeloma for him. After that, He received melphalan and thalidomide for two months. The patients referred to Clinic again with a new oral lesion. In his treatment follow-up and biopsy from his new oral lesion, pathologist reported plasmacytoma. He was treated with radiotherapy(5.000 cGy), than received maintenance consisted of thalidomide 50 mg (VAD). He died after three months from treatment with VAD. Conclusion: The SPB is as part of the multifocal disseminated disease MM. Also, radiotherapy (5.000 cGy) and VAD are not optimal treatments for SPB.

Keywords

References

[1]  Dimopoulos MA, Hamilos G. Solitary bone plasmacytoma and extramedullary plasmacytoma. Curr Treat Options Oncol. 3(3):255-9.2002.
 
[2]  Dagan R, Morris CG, Kirwan J, Mendenhall WM. Solitary plasmacytoma. Am J Clin Oncol. 32(6):612-7.2009.
 
[3]  Mendenhall WM, Mendenhall CM, Mendenhall NP. Solitary plasmacytoma of bone and soft tissues. Am J Otolaryngol. 24(6):395-9.2003.
 
[4]  Dimopoulos MA, Moulopoulos LA, Maniatis A, Alexanian R. Solitary plasmacytoma of bone and asymptomatic multiple myeloma. Blood. 96(6):2037-44.2000.
 
[5]  Regezi JA, Sciubba JJ, Jordan RCK. Oral Pathology: Clinical Pathologic Correlations. 4th Edn. Philadelphia, W.B. Saunders. 2003.
 
Show More References
[6]  Barros TP, Savilha FM, Amantea DV, Campolongo GD, Neto LB, Alves N, et al. Plasmacytoma in the oral cavity: A case report. Int J Odontostomat. 5(2):115-118. 2011.
 
[7]  Galieni P, Cavo M, Pulsoni A, Avvisati G, Bigazzi C, Neri S, et al. Clinical outcome of extramedullary plasmacytoma. Haematologica. Jan .85(1):47-51.2000.
 
[8]  Hu K, Yahalom J. Radiotherapy in the management of plasma cell tumors. Oncology (Williston Park). Jan .14(1):101-8.2000.
 
[9]  Romero IL, Campos FA, Damasceno RW, Vital Filho J, Bison SH. Plasmacytoma of the orbit involving lacrimal gland with secondary transformation into multiple myeloma: case report. Arq Bras Oftalmol. 72(2):236-8.2009.
 
Show Less References